KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ:ABMC) today announced that it has received a letter from the Nasdaq Stock Market (NASDAQ) providing the company with an additional 180-calendar-day compliance period, or until November 10, 2008, to regain compliance with the $1.00 minimum bid price rule set forth in NASDAQ Marketplace Rule 4310(c)(4) (the Rule). The letter states that although ABMC has not yet regained compliance with the Rule, it has met all initial inclusion criteria for the NASDAQ Capital Market as set forth in Marketplace Rule 4310(c), except for the bid price. Accordingly, ABMC has been granted a 180-day extension to regain compliance with the minimum bid price requirement. To regain compliance, anytime before November 10, 2008, the bid price of the Company’s common shares must close at $1.00 per share or more for a minimum of 10 consecutive business days. ABMC shares will continue to be traded on NASDAQ during the 180-day extension period.
